- Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembolica RegistryPublikace bez příslušnosti k fakultě
- Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis2018 | 1. lékařská fakulta
- Dulaglutide and Cardiovascular and Heart Failure Outcomes in Patients With and Without Heart Failure: A Post-hoc Analysis from the REWIND Randomized Trial2022 | Publikace bez příslušnosti k fakultě
- Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome2020 | Publikace bez příslušnosti k fakultě
- Závěrečná zpráva Fakultní nemocnice Hradec Králové ke klinickému hodnocení protokol č. PM1116197Publikace bez příslušnosti k fakultě
- Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure2021 | Lékařská fakulta v Plzni
- CT or Invasive Coronary Angiography in Stable Chest Pain2022 | 2. lékařská fakulta
- Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes2019 | Publikace bez příslušnosti k fakultě
- Kanagliflozin2023 | 1. lékařská fakulta
- Is There Really an Association of High Circulating Adiponectin Concentration and Mortality or Morbidity Risk in Stable Coronary Artery Disease?2020 | Lékařská fakulta v Plzni, 1. lékařská fakulta
- The power and wisdom of prevention. Cardiovascular risk, new challenge, and approach to PLWH2022 | 3. lékařská fakulta, 1. lékařská fakulta
- Klinické aspekty aspirinové rezistence2017 | 1. lékařská fakulta
- OCT guidance during stent implantation in primary PCI: A randomized multicenter study with nine months of optical coherence tomography follow-up2018 | Lékařská fakulta v Hradci Králové
- Benefits and risks of clopidogrel use in patients with coronary artery disease: Evidence from randomized studies and registries2008 | Ústřední knihovna, 3. lékařská fakulta
- "Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: An intravascular ultrasound study"2006 | Publikace bez příslušnosti k fakultě
- Randomized Comparison of Endothelial Progenitor Cells Capture Stent Versus Cobalt-Chromium Stent for Treatment of ST-Elevation Myocardial Infarction. Six-Month Clinical, Angiographic, and IVUS Follow-Up2010 | Ústřední knihovna, 3. lékařská fakulta
- Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)2010 | 2. lékařská fakulta
- Místo sitagliptinu v léčbě pacientů s diabetem 2. typu po studii TECOS2016 | 2. lékařská fakulta
- Kardiovaskulární bezpečnost substituční terapie testosteronem: komentář ke studii TRAVERSE2023 | 3. lékařská fakulta
- Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial2017 | 2. lékařská fakulta
- In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events2020 | Publikace bez příslušnosti k fakultě
- Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial2022 | Publikace bez příslušnosti k fakultě
- Randomized comparison of 9-month stent strut coverage of biolimus and everolimus drug-eluting stents assessed by optical coherence tomography in patients with ST-segment elevation myocardial infarction. Long-term (5-years) clinical follow-up (ROBUST trial)2023 | Publikace bez příslušnosti k fakultě
- Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention2012 | Lékařská fakulta v Plzni
- Prognostic Value of MicroRNAs in Patients after Myocardial Infarction: A Substudy of PRAGUE-182019 | Lékařská fakulta v Plzni, 3. lékařská fakulta
- Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants2021 | Publikace bez příslušnosti k fakultě
- Polypill Strategy in Secondary Cardiovascular Prevention2022 | 1. lékařská fakulta
- Relationship between TRAIL and Left Ventricular Ejection Fraction in Patients with ST-Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention2018 | 3. lékařská fakulta
- The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus2021 | Publikace bez příslušnosti k fakultě
- Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study2019 | 3. lékařská fakulta